Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014–2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China

Background: Bloodstream infection (BSI) caused by Klebsiella pneumoniae (KP), especially carbapenem-resistant KP (CRKP), results in high morbidity and mortality. Aims: We aim to identify risk factors that associated with the mortality of patients with KP BSI, as well as predictors of developing CRKP...

Full description

Bibliographic Details
Main Authors: Haiyan Chang, Jie Wei, Wanqing Zhou, Xiaomin Yan, Xiaoli Cao, Lingyun Zuo, Shixing Chen, Kefang Yao, Rui Huang, Yuxin Chen, Chao Wu
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Journal of Infection and Public Health
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034119303557
Description
Summary:Background: Bloodstream infection (BSI) caused by Klebsiella pneumoniae (KP), especially carbapenem-resistant KP (CRKP), results in high morbidity and mortality. Aims: We aim to identify risk factors that associated with the mortality of patients with KP BSI, as well as predictors of developing CRKP BSI. Results: In this retrospective cohort study, we examined 285 inpatients with BSI caused by KP in a tertiary hospital in China between 2014 and 2018, and 46 patients were infected with CRKP. We identified that hematological tumor (odds ratio (OR): 8.359, [95% CI: 2.162–33.721], P = 0.002), CRKP isolation (OR: 7.766, [95% CI: 2.796–21.576], P = 0.001), chronic lung disease (OR: 5.020, [95% CI: 1.275–19.768], P = 0.020), and septic shock (OR: 4.591, [95% CI: 1.686–12.496], P = 0.003) were independent risk factors for the death of KP BSI. A 28-day mortality of KP BSI score ranging from 0 to 22 was developed based on the above 4 independent variables. Our scoring system revealed that the 28-day mortality were 9.14%, 35.29%, 38.10 %, 75% and 100% for carriers with a score of 0, 5, 6–10, 11–13 and ≥14, respectively. Additionally, CRKP infection were independently associated with intensive care unit stay (OR: 5.506, [95% CI: 2.258–13.424], P = 0.001), exposure to antifungals (OR: 4.679, [95% CI: 2.065–10.063], P = 0.001), exposure to fluoroquinolones (OR: 2.892, [95% CI: 1.151–7.267], P = 0.020), and the number of isolated bacterial species from the patient ≥ 3 (OR: 2.414, [95% CI: 1.306–4.463], P = 0.005). Conclusion: Our study may be useful for the reduction of the mortality of patients with KP BSI and the prevention of developing CRKP BSI in hospitals. Keywords: Bloodstream infections, Carbapenem resistance, Klebsiella pneumoniae, Risk factors, Mortality
ISSN:1876-0341